By Jocelyn Aspa and Bryan Mc Govern
The Canadian cannabis sector is taking huge steps in establishing guidelines for their product and finding international opportunities in the medical landscape, while the recreational market will officially be legalized come July 1, 2018.
Down in the US, a number of states are in various phases of legalization for both medical and recreational marijuana use. Similarly, while it’s still well over a year until recreational use is legalized in Canada, this can make the market confusing, or even a little risky, for new investors. That said, there are good opportunities out there for those willing to do their research.
With that in mind, here’s a look at a variety of publicly traded Canadian marijuana stocks. The list includes cannabis and hemp focused stocks listed on Canadian exchanges.
Abattis Bioceuticals (CSE:ATT)
Abattis Bioceuticals is a vertically integrated biotechnology company focused on natural health products, including cannabis. The company develops natural health products and conducts research and development for the pharmaceutical, nutraceutical, bioceutical and cosmetic markets.
In April 2017, the company announced it had signed an exclusive distribution agreement for proprietary extraction technology.
ABcann Global (TSXV:ABCN)
ABcann became public this year with a complete TSXV listing. This licensed producer is set to expand with additions to their staff and new 100,000-square-foot facility set to add to their current 625 kilograms per year production.
The company evaluates its product under a climate controlled chamber, which allows it to put out a uniform product and be safer when it comes to new Health Canada randomized inspections on cannabis from its producers. In July, ABcann announced its listing on the OTCQB Marketplace and Frankfurt Stock Exchange. Prior to that, it–together with Cannabis Wheaton–announced the signing of an agreement for the first tranche of a $15 million placement.
Alliance Growers (CSE:ACG)
In its attempt to scale up on the cannabis market from a regional, national and international scope, ACG has moved to develop a Cannabis Botany Centre with Botanical Research In Motion International to jointly develop and operate multiple cannabis-focused Botany centers in Canada.
The company most recently announced on June 30 an update on streaming financing, which includes funding of the Cannabis Botany Centre.
Alternate Health (CSE:AHG)
This technology company is putting its efforts into innovation in complementary medicine, clinical research, and medical cannabis. Thanks to these partnerships, Alternate Health is working on inspecting all medical venues of cannabidiol and other cannabinoids.
In May 2017, the company announced it received approval from the Accreditation Council for Continuing Medical Education in partnership with the American Medical Association for a detailed training program for doctors on Chronic Traumatic Encephalopathy and Cannabis.
“Through our partnership with the University of Louisville, we have created an educational series that instructs doctors how to use cannabis as an emerging treatment for CTE and other medical disorders,” said in a statement Dr. Jamison Feramisco, CEO of Alternate Health.
Alternate Health’s most recent news came on July 3, when it announced a change to its testing laboratory structure. The press release states that the changes will “maximize” profitability while positioning the company to service a larger base than currently available.
Also licensed under the ACMPR, much like other companies on the Canadian marijuana stocks, Aphria is located in Learnington, Ontario.
The company self-describes itself as “truly powered by sunlight”, which they state allows for natural growing conditions to produce safe medical cannabis products.
Last June, the company announced it expects to more than double its growing capacity—the company’s board approved in September a $24.5 million project increasing its greenhouse square footage from 100,000 to 300,000 square feet, expected to be completed later this year. The company expects that the expansion will be able to bump growing capabilities from 5,500 kilograms to 18,000 kilograms annually.
Aphria is also in the midst of completing its previously disclosed 57,000 square foot Part II expansion, is on target for full crop rotation by June 2017. In early February, the company announced that it moved from the TSX Venture Exchange to the TSX Exchange. A week later, Aphria announced a $50 million bought deal financing.
Putting it simply, 2017 has also been a busy year for Aphria, and with the legalization date set for recreational use, that isn’t about to stop. In April, the company announced it had secured a $100 million raise–$75 million of which will be used for a bought deal equity financing, with the remainder a debt financing through a five-year term loan. In early July, the company announced it had received a major wholesale supply agreemnet with Scientus Pharma, a licensed dealer under Health Canada.
Aurora Cannabis (TSX:ACB)
Next on our Canadian marijuana stocks is Aurora Cannabis.
The company’s production facilities are located in Mountain View County, Alberta, near the Rocky Mountains. The company aims to “produce the cleanest, safest medical cannabis available on the market,” and all of its strains are currently offered at $8 per gram.
On September 2, 2016, Aurora surpassed 7,700 active registered patients, just under eight months after the Company’s first sale of the product. In November 2016, the company announced construction had begun on its 800,000 square foot Aurora Sky expansion, with a target completion for October 2017. In December, Aurora announced the production facility would be located at the Edmonton International Airport. Subject to conditions, the company notes it will lease 30 acres from the Edmonton Regional Airports Authority.
Much like the companies listed above, 2017 has been a boisterous year for the company. For example, at the end of March, the company became the first Canadian producer to begin trading on the OTCQX Best Market in the US. Not long after–at the beginning of April–the company completed the acquisition of Peloton Pharmaceuticals, a stage ACMPR applicant. Then in June, Aurora announced it had surpassed 16,000 patients, prior to graduating from the TSXV to the TS.
Beleave is a biotech company with a focus on becoming a licensed producer of medical-grade cannabis under the ACMPR. Its wholly-owned subsidiary, First Access, applied for a pre-license inspection in March 2017.
Following that, on May 5 the company announced it had entered into an interim streaming agreement with PanCann to finance the purchase and construction of a second production facility. In mid-May, Beleave finally announced it had received its ACMPR license to cultivate medical cannabis.
Calyx Bio-Ventures (TSXV:CYX)
Calyx is an agri-tech company listed here on our Canadian marijuana stocks list and owns a portfolio of proprietary intellectual property with applications in crop enhancement, as well as a software platform tailored to the advanced indoor agriculture sector.
In October 2016, the company announced that its wholly-owned subsidiary, Cannigistics Agri-Solutions, launched its first consumer-facing cloud-based off the company’s FocusPoint Software Platform.
Canadian Bioceutical (CSE:BCC)
Through its subsidiaries and investments in several states in the US, BCC is involved in the American cannabis market.
The company applied for a Canadian licensed producer (LP) status, but due to a rocky unresponsive process decided to mobilize its investments in the US. On May 22, 2017, the company officially began trading on the OTCQB Market.
Cannabis Wheaton Income (TSXV:CBW)
A fairly new entrant to the Canadian cannabis sector, Cannabis Wheaton, was formed to provide funding for facility expansions, operations, and initial construction. In return, the company gets minority equity interests and a percentage of the cultivation. Their team includes a group of experienced people in the area like the co-founder of Canopy, Chuck Rifici, who is the CEO of Cannabis Wheaton.
According to the CBC, the company already has 16 streaming deals and four of those include licensed producers: Broken Coast Cannabis, Green Relief, Evergreen Medicinal Supply and Harvest One. At the end of June, the company announced the closing of a $50.2 million offering
Cannabix Technologies (CSE:BLO)
On the technology side of things, Cannabix Technologies is developing a breathalyzer that detects THC for use by law enforcement.
At the end of March 2017, the company provided an update on its live testing of the Cannabix Marijuana Breathalyzer, citing that preliminary human subject testing during March produced “excellent results.”
CannaRoyalty puts together its platform of holdings through royalty agreements, equity interests, convertible debt and licensing agreements across Canada and the US. This Canadian marijuana stocks company has also joined the wave of companies being added to the OTCQX Market. On April 26, CannaRoyalty begun trading on the OTCQX under the symbol ‘CNNRF’. Most recently, CannaRoyalty announced it had secured its first engagement with Alternative Medical Enterprises.
CanniMed Therapeutics (TSX:CMED)
CanniMed has 15 years of pharmaceutical cannabis cultivation experience and GMP-compliant production process to back up its medical cannabis services.
The company is involved in the international market and was able to complete the shipment for the first commercial cannabis oil to enter Australia, thanks to a permit from the Australian Department of Health.
Canopy Growth (TSX:WEED)
Canopy Growth is, indeed, the largest Canadian marijuana stocks company, having been the first cannabis organization to surpass the $1 billion market cap.
Canopy holds producers Tweed and Bedrocan under its umbrella. Tweed’s production facility is located in the old Hershey factory in Smith Falls, Ontario, while its breeding facility was completed in September 2016. The company believes the state-of-the-art facility is the first of its kind and will form the foundation of new Canadian-bred genetics.
Near the end of May 2016, Canopy Growth announced it would be expanding into Australia through a partnership with AusCann Group Holdings. The company also announced on September 15, 2016, that it launched its first DNA Genetics strain, Lemon Skunk, in its Tweed store. Tweed has also launched a new seed breeding area which will serve as a massive accelerator towards innovating product development and expanding quality and variety.
Mettrum Health, one of the first medical cannabis producers in Canada to be licensed under the Marihuana for Medical Purposes Regulations (MMPR)–now the Access to Cannabis for Medical Purposes Regulations (ACMPR) as of August 24, 2016–is a vertically integrated provider of cannabis products. It operates three facilities in Ontario with an annual production capacity of 12,000 kilograms. Mettrum offers a range of products in both whole-bud and extracts forms.
Under Canopy’s acquisition, in January 2017, Mettrum Health announced it had acquired Bodystream Cannabis Clinic network, which includes 14 medical cannabis clinics located across Ontario.
In April 2017, Canopy Growth announced the launch of its ‘first-in-class’ Craft Grow program, which opens to access in genetics, knowledge and retail infrastructure, and committed to $20 million in seed capital funding.
Cronos Group (TSXV:MJN)
The Cronos Group rebranded from PharmaCan to become Cronos Group in October 2016, with a vision to become Canada’s first bi-coastal licensed producer with interests in five licensed producers and three licensed applicants.
Cronos Group owns 100 percent interest of Peace Naturals, a company licensed to produce and sell medical marijuana, and also cultivate cannabis oil. On January 11, the company was granted its second Health Canada sales license through its wholly-owned subsidiary, Zone Produce. In February, the company announced a $15 million bought deal with Eight Capital. At the beginning of May 2017, the Cronos Group announced its 2016 financial results and also released an announcement stating it had been awarded a Good Manufacturing Practice certification.
Emerald Health Botanicals (TSXV:EMH)
Emerald Health Botanicals, previously Emerald Health therapeutics, is a licensed medical marijuana producer under MMPR. As a federal research grant recipient, the company conducts research and development into the characterization of cannabis strains and cultivation technologies. It also collaborates with academic and medical research to help gain further understanding of the effect of cannabis on humans.
Like most other Canadian marijuana stocks, Emblem is a licensed producer in Canada, currently using the latest in indoor grow science. The company’s new facility located in Ontario was designed with a purpose to cultivate and cure cannabis for medicinal use. Emblem gave the go-ahead in December 2016 from Health Canada to begin production of cannabis oil.
On April 17, 2017, the company announced the granting of 280,000 incentive stock options. At the end of May, Emblem announced it had entered into an agreement to acquire two land for production capacity expansion ahead of legalization in Canada in 2018.
Friday Night (CSE:TGIF)
Friday Night is a cannabis producer based on the state of Nevada, one of the states to most recently legalized the recreational use of cannabis.
The company raised $7.5 million in order to fully capitalize on the high demand of the market in Las Vegas. On June 15, the company began trading on the CSE.
Global Cannabis (CSE:APP)
Global Cannabis runs a mobile application business related to the cannabis industry. Their products include Citizen Green, Foro, Opinit and Truth.
The company plans to roll out the launch of their cannabis lifestyle apps CannaLife and CannaMed. Most recently, the company announced at the end of June that it will launch Citizen Green’s CannaMed and CannaLife apps.
Golden Leaf Holdings (CSE:GLH)
Listed in Canada but located in Oregon, Golden Leaf Holdings is focused on producing high-quality cannabis oils. Currently, the company’s portfolio of brands is to meet the needs of patients, consumer and strategic partners.
On January 9, Golden Leaf announced it had received its recreational processor and wholesaler license for its Portland-based facility, as well its recreational retailer license for the Left Coast Connection dispensary. Then in March, the company signed a binding letter of agreement to obtain cannabis licenses in Nevada. In May, Golden Leaf reported its 2016 audited results. Its most recent news came in July, when Golden Leaf Holdings announced it had met the outstanding conditions of the escrowed funds from its $35 million private placement of subscription receipts.
Harvest One Cannabis (TSXV:HVST)
Harvest One conducts its business thanks to three different units, United Greeneries provides the horticultural arm while Satipharm AG serves the medical arm. Those two are under the Harvest One umbrella. Each business is strategically located with supportive regulatory frameworks in place. United Greeneries has received a Canadian medicinal cannabis cultivation license.
The company announced on May 9 it had completed its first international shipment, with product heading to Australia.
High Hampton Holdings (CSE:HC)
Thanks to its subsidiary the company offers a variety of services to licensed producers in Canada like propagation, direct cultivation, and sale of purebred cultivars, cloning, and marijuana strain storage. All of this in order to improve profit margins and add to these companies’ bottom line.
Earlier in 2017, the company announced it was working on a closely $5 million brokered private placement deal. High Hampton also announced it was in the process of acquiring CoachellaGro working on the legal production plan in the city of Coachella, California.
Also a licensed producer the company sells their product through their website and grows it under a glass roof greenhouse, which makes it so their crops receive direct sunlight.
Hydropothecary went public in March following a couple of false starts, according to the Financial Post, the company joined the TSXV due to the potential from legalization on the recreational market.
The company paused sales and shipment of all its product after a random Health Canada test revealed low levels of myclobutanil in their crops. On May 8, the company announced had found no contamination from myclobutanil on 20 lot samples. While on May 6, the company sad over 200 samples had been logged for testing. Health Canada is heavily involved in this situation.
The Globe and Mail reported it was still unclear whether the company would issue a recall.
At the end of June, Hydropothecary announced its Q3 2017 results, highlighting shipments for the quarter were up 51 percent compared to the prior quarter.
This company offers financing options to other cannabis cultivators, processors, and dispensaries in the US. The company has deals with licensed producers in four states: Colorado, Massachusetts, New Mexico and Vermont. By guiding these many companies iAnthus has a solid grasp on the cannabis sector in America.
iAnthus currently has almost 20 million invested in five cannabis operations since the start of 2016. “We look forward to making additional investments in greenfield states as well as acquiring assets that have strong track records of revenue growth and cash flow generation,” Julius Kalcevich, CFO of iAnthus, said in a statement.
InMed Pharmaceuticals (CSE:IN)
InMed is developing therapies for patients through the research of cannabinoids in combination with drug delivery systems. The company has a dermatology product with clinical trials planned all throughout 2020.
On July 10, the company announced it had signed a research and development agreement with ATERA, a company that specializes in the development of advanced human tissue models. As part of the agreement, ATERA will work to develop 3D human skin models of Eipdermolysis Bullosa to evaluate the vitro drug efficacy of InMed’s lead product, INM-750.
International Cannabis (TSXV:ICC)
This licensed integrated cannabis company operates out of Uruguay, a leader in the legal cannabis space and a model many other countries have looked for a similar strategy.
ICC is also investing in cannabis research to improve understanding of its physical uses and medical benefits.
Invictus MD (TSXV:IMH)
Invictus hosts a platform for cannabis, located in Vancouver, the company wants to capitalize on the upcoming cannabis legalization process the federal government is set to take.
This Canadian marijuana stocks company recently brought Acreage Pharms, a licensed producer located in Alberta, under its corporate umbrella.
“[W]e now have 250 acres of cultivation space that stretches from Alberta to Ontario. Acreage Pharms will benefit from a low cost of production as a result of low energy and water costs,” Dan Kriznic, executive chairman of Invictus said in a statement. “Additionally the property is friendly to building as many square feet as required based on the significant demand, which Deloitte reports to be between $4.9 billion and $8.7 billion annually.”
Invictus announced in April 2017 an agreement with Canopy Growth to allow the sale of the product from AB Labs, which was partly acquired by Invictus last year, on the Tweed Main Street’s online store. On June 23, Invictus announced it had been included on the Horizons Marijuana Life Sciences Index ETF.
Isodiol International (CSE:ISOL)
Through its own online store, Isodiol offers a variety of cannabidiol (CBD) products like oils, sprays, and patches. The company has developed proprietary ISO 9001 and GMP-certified cannabinoid production and purification methods to formulate high quality CBD products.
Isodiol is one of the first Canadian companies to express an interest in entering the Mexican market, following medical legalization in the country. Isodiol announced in early July that it had received approval from the Brazilian Health Regulatory Agency for its pharmaceutical grade Cannabidiol product, Isoderm.
Lexaria Bioscience (CSE:LXX)
Lexaria is food biosciences company that has the technology for improved delivery of bioactive compounds. In particular, the company offers a variety of hemp oil products to its consumers and also has some novel food offerings like a black tea infused with hemp oil.
Lexaria has filed patents in the US to protect their lipid-based delivery mechanisms. On June 23, the company announced the filing of a new provisional patent application and stock and option awards.
Kalytera Therapeutics (TSXV:KALY)
This clinical-stage pharmaceutical is working on developing the latest in therapies available through the use of cannabis. Kalytera is developing a new class of proprietary CBD therapeutics.
At the end of May, Kalytera announced its first quarter 2017 financial results, highlighting that the company was spending $404,000 in research and development.
Liberty Leaf (CSE:LIB)
Liberty Leaf has the objective to be at the forefront of the medicinal and recreational cannabis industry. Located in Vancouver, the company signed a memorandum of understanding in November 2016 to acquire a interest in Oakland, California, a cannabis cultivation product manufacturer license holder.
In early February, Liberty Leaf announced it had signed a letter of intent to acquire a 27.5 percent interest in Gr8 Track, a private California company licensed to produce medicinal cannabis. In March 2017, Liberty Leaf was added to the CSE index, and then received approval to expand to the US on the OTCQB Marketplace in April 2017. Most recently, in mid-July 2017, Liberty Leaf announced it had added cannabis oil to its proposed products line.
Maple Leaf Green World (TSXV:MGW)
Maple Leaf Green World is involved in a number of different projects around the globe. In California, the company is joint-ventured with a non-profit collective for a growing facility. The company is also involved in an eco-agriculture venture in China, focused on growing value-added tree seedlings.
On January 4, Maple Leaf announced it had received notice from Health Canada that its application to become a licensed producer under the Access to Cannabis for Medical Purposes Regulations, and is now preparing their Telkwa, BC facility with the a goal of preparing for a pre-license inspection by Health Canada. At the end of January, the company announced it had secured a site for a facility in Nevada. Then in February, the company announced its intentions to raise $5 million.
As of May 1, the company had received conditional approval to begin trading on the TSX Venture Exchange. On June 30, Maple Leaf Green World provided an update on its American cannabis medical operations, stating it had purchased four acres of industrial land in Henderson, Nevada.
Marapharm Ventures (CSE:MDM)
Marapharm Ventures has two operations in British Columbia. The company’s initial facility–a proposed 22,000 square feet area –will be on an 11-acre site in Kelowna.
Marapharm has also purchased land in Las Vegas for the purpose of building a facility that will host three medical marijuana licenses. What’s more, the company also has the opportunity in Washington to lease a facility to a tier 3 license holder.
On July 4, Marapharm announced the approval of two more recreational licenses in Las Vegas, Nevada.
Maricann is relatively new to the Canadian marijuana stocks, having joined the CSE under the symbol MARI on April 24th. Maricann expects to be finished with the construction of their Langton facility in 2017, which will up their production square footage from 44,000 to 217,500.
In May 2017, the company received financing of $42,500,000 to expand their production results in Germany.
MedReleaf is working to advance the knowledge available on the therapeutic benefits of cannabis for patient care.
MedReleaf raised $100.7 million for its IPO earlier this year, becoming one of the biggest cannabis-related IPO ever. Unfortunately the stock suffered a 22 percent decline from its projected price on its first public day.
MYM Nutraceuticals (CSE:MYM)
Our next Canadian marijuana stocks company is MYM Nutraceuticals, another biopharmaceutical company, and distributor of medical marijuana. It has applied to Health Canada for a production license under MMPR and considers itself well prepared for distribution of medical marijuana, and a growing facility property.
On February 22, the company announced it had closed the acquisition of an inspection stage licensed producer application, Sublime Culture. In May 2017, MYM announced an update to its HempMed sales, citing that sales had increased by more than 35 percent from the previous year’s average.
Most recently, MYM announced that it and GGS Structures are working on the Weedon Greenhouse Project.
Naturally Splendid (TSXV:NSP)
Naturally Splendid has a slightly different focus than some of the other companies here on the Canadian marijuana stocks list. Rather than being involved in the medical marijuana space, the company offers investors exposure to the hemp-based healthy foods and omega markets. It is the only publicly traded company in the world offering investors exposure in this area. Naturally Splendid also has a sister company listed on the OTC, Laguna Blends (OTCMKTS:LAGBF), which is focused on the nutritional health benefits of hemp.
In April 2017, the company signed an executive sales agreement with Laguna Blends (CSE:LAG) for the marketing of CBD formulated cosmeceutical products. Following that, Naturally Splendid reported its 2016 results, highlighting $7.34 million in revenue.
On July 12, the company announced it had entered into a letter of intent to acquire a natural food company.
Through its subsidiary, Up Cannabis, Newstrike plans on developing various cannabis brands which would address medical client needs and as full legalization rolls into the country, recreational consumers as well.
This licensed producer inked a deal with the Canadian band The Tragically Hip to contribute creatively to the company’s efforts.
As its name suggests, OrganiGram specializes in producing organically grown medical marijuana. The company is licensed under the ACMPR and has a production facility located in Moncton, New Brunswick.
The company entered into an exclusive product development and distribution agreement with TGS International in September 2016. TGS is an affiliate of the Green Solution, a major Colorado marijuana dispensary, and will provide consulting for the development and operation for OrganiGram’s new production and processing facility.
In early 2017, Organi announced it had acquired additional lands and premises adjacent to its existing property in Moncton, while in March the company acquired a production license renewal under the ACMPR. Indeed, 2017 has been a busy year for OrganiGram: in May, the company announced that it had completed a sales agreement with Advanced Extraction Systems for the purposes of building a series of custom CO2 Supercritical Fluid Extraction (SFE) Systems for producing high-quality cannabis extracts on a commercial scale.
PUF Ventures (CSE:PUF)
PUF Ventures has a diversified portfolio of assets in the Canadian marijuana sector. It owns a passive, non-controlling interest in AAA Heidelberg, which is focused on using all-natural nutrients to grow healthy, pest free plants.
AAA Heidelberg has had an MMPR application pending with Health Canada since 2013. Other ventures the company has invested in include 1313 Cigs, VapeTronix, and Weed Beacon. In late January, the company announced it had recommenced its development of the WeedBacon platform.
Quadron Capital Corporation (CSE:QCC)
Quadron works to help licensed producers in Canada with “complex needs and requirements” through equipment, products, and services. The company also offers dispensing devices and consumption products.
The company has two subsidiaries in Soma Labs Scientific, Greenmantle, and Cybernetic Control Systems.
In February, this particular Canadian marijuana stocks company began trading publicly on the TSXV under the symbol QCC. In May 2017, it was announced Quadron would be renaming to Quadron Cannatech as a reflection of the company’s “evolving focus” on the cannabis space.
Radient Technologies (TSXV:RTI)
Radient is an extraction technology company that has dabbled in the cannabis sector thanks to a partnership with licensed producer Aurora Cannabis. The partnership was unveiled this year and since then the two companies have provided an update on the status of their collaboration.
A press release from Aurora revealed the intention behind this partnership was to achieve a superior standardized cannabinoid extracts.
“The potential to substantially increase our extracts production capacity while maintaining terpene profiles would further differentiate our Company, and we are excited to be exploring this opportunity further in the coming weeks,” said Aurora’s CEO Terry Booth in the same release.
“Ensuring patient confidence in the purity and safety of the cannabis products they consume is, in our view, a prerequisite for a properly functioning market,” said Radient CEO, Denis Taschuk, in a statement.
Supreme Pharmaceuticals (TSXV:SL)
Supreme Pharmaceuticals is next on our Canadian marijuana stocks list. Located in Kincardine, Ontario, the company’s federally approved medical marijuana company, 7ACRES, cultivates medical marijuana on a greenhouse cost base. Along with 24 other companies, Supreme received its Federal license in March of 2016.
In December 2016, Supreme announced it had closed a $55 million offering, with the intention to use the net proceeds to expand its hybrid greenhouse facility in Kincardine. On April 10, 2017, Supreme announced it had also received conditional approval to list on the TSXV.
Another fairly new member of the Canadian cannabis sector is TerrAscend, who went public in May 2017 when it entered the Canadian Securities Exchange. The company’s subsidiary, Solace Health, is in the process of applying for an official licensing designation from Health Canada. Solace is host to a 67,000 square feet production facility
The company’s other subsidiary Terra Health Network is a research-based cannabinoid medical group, which wants to improve the medical cannabis solutions available for patients with chronic pain and debilitating illnesses.
Tetra Bio-Pharma (CSE:TBP)
Much like a number of other Canadian marijuana stocks, Tetra Bio-Pharma is focused on combining traditional methods of medicinal cannabis use together with scientific validation for inclusion in the existing bio pharma industry.
In that regard, the company announced in January that had appointed Dr. Gilles Chamberland to its scientific and clinical advisory board. Then in February, Tetra Bio-Pharma announced it had received approval from Health Canada for its Phase I clinical study of smoked cannabis.
On April 19, Tetra Bio-Pharma announced that–with previously listed Canadian marijuana stocks company–Aphria, plans for the joint distribution of dried medical cannabis in the maritime provinces and Quebec. At the end of June 2017, Tetra Bio-Pharma announced it had expanded its focus into the veterinary market.
THC Biomed (CSE:THC)
Next on the Canadian marijuana stocks list is THC Biomed, who has been granted permission to conduct research and development for scientific purposes with medicinal marijuana. The company provides scientific and biotechnical services to current and potential licensed producers. In May 2016, Health Canada granted TCH BioMed a license to produce fresh marijuana, cannabis oil and cannabis resin.
On May 8, THC Biomed announced the purchase of Clone Shipper–a US based company specializing in packaging products for transportation of live plants– for $1 million.
Tinley Beverage (CSE:TNY)
Tinley Beverage is the producer of Hemplify, a drinkable vitality supplement containing hemp extract made from the stalk of industrial hemp. The vegan, sugar-free drink is a source of electrolytes, vitamins and Omega 3 fatty acids. The company reported receiving its first orders for Hemplify products on March 10, 2016. In August 2016 the company launched its web store at www.drinkhemplify.com and listed its flagship “Hemplify” product for sale on Amazon.com.
True Leaf Pet (CSE:MJ)
Canada-based True Leaf is slightly different than the afore-mentioned Canadian marijuana stocks; the company is focused on the production of hemp-based functional dog chews. In August 2016, the company secured the first order for its True Hemp pet products with Pets Corner, the second largest pet store chain in the United Kingdom. The store will sell the product in all of its 174 stores. The sale also means that True Hemp is now generating revenue on two continents – North America and Europe. “We’re on our way to becoming a truly global brand,” said CEO Darcy Bomford.
In January 2017, True Leaf completed the purchase of an animal-care product company, OregaPet, which produces medicinal products for animals. In February, True Leaf Pet announced that it had entered into an agreement with Liberty Premium Pet Products in New Zealand to distribute dog chews in retail stores across the country. In May, True Leaf Pet announced its intentions to close a non-brokered private placement for $3 million. At the end of May, True Leaf announced the first tranche closing of a private placement worth $200,000.
Valens GroWorks (CSE:VGW)
Located in British Columbia’s Okanagan Valley, our next Canadian marijuana stocks is Valens GroWorks, a “rapidly emerging” with a focus on cannabis cultivation and research.
As of January 13, 2017, the company has completed the licensing inspection by the Regional Inspectorate of the Office of Controlled Substances of Health Canada. This includes the final inspection of the company’s wholly-owned subsidiary, Valens Agritech’s 17,000 square foot facility in Kelowna.
Veritas Pharma (CSE:VRT)
Veritas is working on fully understanding the medical capabilities of marijuana, the company’s mission is to find the most effective strains that target a specific disease condition. Veritas is using a specifically designed approach to their research where they chemically and pharmacologically profile the plant. As a last check, they complete a clinical study of each cultivar.
In April 2017, the company acquired Cannevert Therapeutics, a group of chemists, pharmacologists and other medical professionals with permission from Health Canada to perform research on cannabis. More recently, the company announced its plans to build a cannabis cultivation facility
Vinergy Resources (CSE:VIN)
Rounding out the Canadian marijuana stocks list is, Vinergy is an oil and gas company, that recently acquired MJ BioPharma, a cannabis technology company focused on manufacturing breath strips, time release capsules, extract oils, food products, and infused juices, teas, coffee and extract drinks and pharmaceutical grade delivery systems.
The pair announced in February the had developed an oral cannabinoid complex delivery strips and controlled time release capsule technology. “We think time release capsules are extremely important as they help bridge the gap in terms of familiarity with many patients who want to switch from synthetic drugs to a natural product as a way to reduce side effects and drug,” said Mr. Kent Deuters, CEO of MJ Biopharma.
Vodis Pharmaceuticals (CSE:VP)
Vodis has medical and recreational marijuana business operations in both Canada and the United States. With facilities in BC and Washington State, Vodis is actively seeing expansion opportunities in other countries and US states.
In March, the company announced it, together with Our Church International, signed a 15-year licensing and marketing agreement. Later that month, Vodis announced construction had begun on its Bellingham cannabis facility. Following that, the company announced its USA-branded product had begun selling in Washington State. On June 20, Vodis announced a $5 million private placement financing.
Another officially licensed producer in Canada, WeedMD is focused on the growth of medical cannabis and sells its product directly to customers through their website. In May the company announced they received a sale licence, which expands their business to include the sale of 1,200kg dried medicinal product per year.
Earlier this year the company joined the TSXV. The company is looking to perform an expansion with a 220,000 square feet facility as it prepares for the recreational market to open in Canada. On June 28, it was announced that the company had entered a strategic partnership with Aurora Cannabis. Prior to that, WeedMD announced that it had secured a license from Health Canada to produce cannabis oils.
Wildflower Marijuana (CSE:SUN)
Working exclusively in Washington State, Wildflower Marijuana lists in Canada, with a focus on developing and designing products in the cannabis sector. In December 2016, the company signed a digital media agreement, which includes an overall marketing strategy.
In April 2017, Wildflower announced it had received $435,000 from warrant exercise, proceeds of which will go towards additional inventory and corporate purposes.
Thanks to its expertise in oil and the high demand for cannabis extracts, the company shows potential for growth from cannabidiol extractions.
On June 27, Wildflower announced that its products would soon be coming to Amazon.com–which shouldn’t come as a surprise. Earlier in June, the company announced a brand expansion into the American market.
Did we miss a company that you think should be included on the Canadian marijuana stocks list? Let us know in the comments!
This article has been updated since its original publication in 2016, with the most recent update done by Bryan Mc Govern.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Jocelyn Aspa and Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: Mettrum Health, Naturally Splendid, Maple Leaf Green World, DOJA, Invictus MD, ABcann Global, Weed MD, Harvest One, PUF Ventures, MYM Nutraceuticals, Valens GroWorks, Lexaria Bioscience, Isodiol International Global Cannabis, and Friday Night are clients of the Investing News Network. This article is not paid-for content.